Prospect Capital Advisors’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-149,745
Closed -$696K 30
2017
Q4
$696K Hold
149,745
0.44% 23
2017
Q3
$1.06M Hold
149,745
0.57% 24
2017
Q2
$1.08M Buy
149,745
+49,745
+50% +$360K 0.59% 22
2017
Q1
$616K Buy
+100,000
New +$616K 0.43% 21